Targeting the IL4 receptor with MDNA55 in patients with recurrent glioblastoma: Results of a phase IIb trial. Read more about Targeting the IL4 receptor with MDNA55 in patients with recurrent glioblastoma: Results of a phase IIb trial.
Antibodies to varicella-zoster virus and three other herpesviruses and survival in adults with glioma. Read more about Antibodies to varicella-zoster virus and three other herpesviruses and survival in adults with glioma.
Prognostic validation of a new classification system for extent of resection in glioblastoma: A report of the RANO resect group. Read more about Prognostic validation of a new classification system for extent of resection in glioblastoma: A report of the RANO resect group.
Hypermitotic meningiomas harbor DNA methylation subgroups with distinct biological and clinical features. Read more about Hypermitotic meningiomas harbor DNA methylation subgroups with distinct biological and clinical features.
A phase I/II study of intrathecal trastuzumab in human epidermal growth factor receptor 2-positive (HER2-positive) cancer with leptomeningeal metastases: Safety, efficacy, and cerebrospinal fluid pharmacokinetics. Read more about A phase I/II study of intrathecal trastuzumab in human epidermal growth factor receptor 2-positive (HER2-positive) cancer with leptomeningeal metastases: Safety, efficacy, and cerebrospinal fluid pharmacokinetics.
Corrigendum to: Molecular biomarker-defined brain tumors: Epidemiology, validity, and completeness in the United States. Read more about Corrigendum to: Molecular biomarker-defined brain tumors: Epidemiology, validity, and completeness in the United States.
Launch of an Editorial Scholars Program for Neuro-Oncology. Read more about Launch of an Editorial Scholars Program for Neuro-Oncology.
Isocitrate dehydrogenase (IDH) mutant gliomas: A Society for Neuro-Oncology (SNO) consensus review on diagnosis, management, and future directions. Read more about Isocitrate dehydrogenase (IDH) mutant gliomas: A Society for Neuro-Oncology (SNO) consensus review on diagnosis, management, and future directions.
Clinical significance and molecular annotation of cellular morphometric subtypes in lower-grade gliomas discovered by machine learning. Read more about Clinical significance and molecular annotation of cellular morphometric subtypes in lower-grade gliomas discovered by machine learning.
Low-risk meningioma: Initial outcomes from NRG Oncology/RTOG 0539. Read more about Low-risk meningioma: Initial outcomes from NRG Oncology/RTOG 0539.
